translate English to French: The US FDA has recently released a 'Guidance for Industry - Revised Precautionary measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and New variant CJD (nvCJD) by Blood and Blood Products'.
La FDA des États-Unis a récemment publié un document d'orientation intitulé Guidance for Industry - Revised Precautionary measures to reduce the possible risk of transmission of Creutzfeldt-Jakob Disease (CJD) and New variant CJD (nvCJD) by Blood and Blood Products.